Rapid Determination of Meropenem in Biological Fluids by LC: Comparison of Various Methods for Sample Preparation and Investigation of Meropenem Stability

被引:14
作者
Kipper, Karin [1 ,2 ]
Anier, Kaili [2 ]
Leito, Ivo [1 ]
Karjagin, Juri [3 ]
Oselin, Kersti [2 ]
Herodes, Koit [1 ]
机构
[1] Univ Tartu, Inst Chem, EE-51014 Tartu, Estonia
[2] Univ Tartu, Dept Pharmacol, EE-51014 Tartu, Estonia
[3] Univ Tartu, Anaesthesiol & Intens Care Clin, EE-51014 Tartu, Estonia
关键词
Column liquid chromatography; UV detection; Pharmacokinetic study in human plasma and urine; Meropenem; PERFORMANCE LIQUID-CHROMATOGRAPHY; PHARMACEUTICAL DOSAGE FORM; CYSTIC-FIBROSIS PATIENTS; ULTRAVIOLET DETECTION; HUMAN PLASMA; COMPARATIVE PHARMACOKINETICS; CARBAPENEM ANTIBIOTICS; DOSE MEROPENEM; SERUM; PHARMACODYNAMICS;
D O I
10.1365/s10337-009-1304-8
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid and sensitive LC-UV method was developed and validated for the determination of meropenem, in human plasma and urine. Meropenem retention time was 4.8 min. Method development was based on comparative analysis of different extraction methods published as well as careful study of meropenem stability in biological samples under different conditions. Best results in plasma sample preparation were obtained from protein precipitation with methanol. LOQ was 0.1 A mu g mL(-1) for plasma and 1 A mu g mL(-1) for urine samples. Meropenem in plasma has low stability at room temperature (< 20% of original content after 12 h), but had acceptable stability when the whole analysis procedure was designed to minimize the exposure of meropenem-containing samples and solutions to temperatures higher than 4 A degrees C. The developed method was applied to a human pharmacokinetic study in patients with acute peritonitis.
引用
收藏
页码:1423 / 1427
页数:5
相关论文
共 37 条
[21]   Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock [J].
Karjagin, J. ;
Lefeuvre, S. ;
Oselin, K. ;
Kipper, K. ;
Marchand, S. ;
Tikkerberi, A. ;
Starkopf, J. ;
Couet, W. ;
Sawchuk, R. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (03) :452-459
[22]  
Kurihara Yuji, 2008, Journal of Infection and Chemotherapy, V14, P30, DOI 10.1007/s10156-007-0576-x
[23]   Pharmacokinetic properties and stability of continuous-infusion meropenem in adults with cystic fibrosis [J].
Kuti, JL ;
Nightingale, CH ;
Knauft, RF ;
Nicolau, DP .
CLINICAL THERAPEUTICS, 2004, 26 (04) :493-501
[24]   High-performance liquid chromatographic determination of meropenem in rat plasma using column-switching [J].
Lee, HS ;
Shim, HO ;
Yu, SR .
CHROMATOGRAPHIA, 1996, 42 (7-8) :405-408
[25]   Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection [J].
Legrand, Tiphaine ;
Chhun, Stephanie ;
Rey, Elisabeth ;
Blanchet, Benoit ;
Zahar, Jean-Ralph ;
Lanternier, Fanny ;
Pons, Gerard ;
Jullien, Vincent .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 875 (02) :551-556
[26]  
Makino Junko, 2002, Japanese Journal of Antibiotics, V55, P77
[27]   Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem [J].
Mattoes, HA ;
Kuti, JL ;
Drusano, GL ;
Nicolau, DP .
CLINICAL THERAPEUTICS, 2004, 26 (08) :1187-1198
[28]   Thermal and alkaline stability of meropenem: Degradation products and cytotoxicity [J].
Mendez, Andreas ;
Chagastelles, Pedro ;
Palma, Eduardo ;
Nardi, Nance ;
Schapoval, Elfrides .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) :95-102
[29]   Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample [J].
Mendez, ASL ;
Dalomo, J ;
Steppe, M ;
Schapoval, EES .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 41 (04) :1363-1366
[30]   Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in pharmaceutical dosage form [J].
Mendez, ASL ;
Steppe, M ;
Schapoval, EES .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 33 (05) :947-954